StockStory.org on MSN

Biogen’s (NASDAQ: BIIB) Q4 CY2025: Strong sales

Biotech company Biogen (NASDAQ:BIIB) reported Q4 CY2025 results , but sales fell by 7.1% year on year to $2.28 billion. Its ...